RSH 3.45% 3.0¢ respiri limited

The Times of India, page-22

  1. 42 Posts.
    lightbulb Created with Sketch. 14
    from what I understand, the initial study is conducted on patients currently presenting to the hospital with asthma symptoms. at such visit, the wheeze sound heard by Dr with stethoscope is compared to Wheezo device's detection of wheeze. so far I believe Prof Thompson has said that Wheezo wheeze defection highly correlates with wheeze detected by stethoscope. I forget how many subjects are needed to complete first study. but assuming there have been that many people admitted to hospital with asthma symptoms, then the conclusion of the first study should be close?
    The second study involves actually inducing an asthma attack, which may be why ethics approval for this second study takes a bit longer to get. Having said this, I believe the second study will be key because it will allow the Prof to translate the sound heard by the stethoscope into a corresponding Wheezo wheeze rate. in turn medical professionals can confidently use this wheeze sound translation when recommending Wheezo to their patients. I'm seeing the light at the end of the tunnel.

    GLTA!!
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.001(3.45%)
Mkt cap ! $38.54M
Open High Low Value Volume
3.1¢ 3.2¢ 3.0¢ $62.15K 2.008M

Buyers (Bids)

No. Vol. Price($)
3 372265 2.9¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 50596 1
View Market Depth
Last trade - 15.40pm 06/09/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.